Entrada Therapeutics
TRDA
TRDA
103 hedge funds and large institutions have $560M invested in Entrada Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 97 → 103 (+6)
5.61% more ownership
Funds ownership: 80.91% → 86.52% (+5.6%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
103
Holding in Top 10
4
Calls
$717K
Puts
$103K
Top Buyers
| 1 | +$6.39M | |
| 2 | +$4.17M | |
| 3 | +$3.47M | |
| 4 |
BlackRock
New York
|
+$2.62M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.12M |
Top Sellers
| 1 | -$5.94M | |
| 2 | -$2.53M | |
| 3 | -$1.7M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.6M |
| 5 |
CC
Corton Capital
Carrying Place,
Ontario, Canada
|
-$924K |